Clevio Nobrega (C Nóbrega, Clévio Nóbrega)

ResearcherID Scopus Author ID Ciência ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Topics

Cognitive Decline

Binding Protein

Top Venues

International journal of molecular sciences

Cell death & disease

Journal of neurochemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Rafael G Costa, André Conceição, Carlos A Matos, Clevio Nobrega
The polyglutamine protein ATXN2: from its molecular functions to its involvement in disease. Cell death & disease 15 (6) (2024)
Rafael G Costa, André Conceição, Carlos A Matos, Clevio Nobrega
The polyglutamine protein ATXN2: from its molecular functions to its involvement in disease. Cell death & disease 15 (6) (2024)
Rafael G Costa, André Conceição, Carlos A Matos, Clevio Nobrega
The polyglutamine protein ATXN2: from its molecular functions to its involvement in disease. Cell death & disease 15 (6) (2024)
David V C Brito, F Esteves, A T Rajado, N Silva, null null, Inês Maria Araújo, José Bragança, P Castelo-Branco, Clevio Nobrega
Assessing cognitive decline in the aging brain: lessons from rodent and human studies. npj aging 9 (1) (2023)
Elena Grao-Cruces, Carmen M Claro-Cala, Sergio Montserrat-de la Paz, Clevio Nobrega
Lipoprotein Metabolism, Protein Aggregation, and Alzheimer's Disease: A Literature Review. International journal of molecular sciences 24 (3) (2023)
Rodrigo Paulino, Clevio Nobrega
Autophagy in Spinocerebellar Ataxia Type 3: From Pathogenesis to Therapeutics. International journal of molecular sciences 24 (8) (2023)
Rodrigo Paulino, Clevio Nobrega
Autophagy in Spinocerebellar Ataxia Type 3: From Pathogenesis to Therapeutics. International journal of molecular sciences 24 (8) (2023)
Bernardo Estevam, Carlos A Matos, Clevio Nobrega
PolyQ Database-an integrated database on polyglutamine diseases. Database : the journal of biological databases and curation 2023 (2023)
Elena Grao-Cruces, Carmen M Claro-Cala, Sergio Montserrat-de la Paz, Clevio Nobrega
Lipoprotein Metabolism, Protein Aggregation, and Alzheimer's Disease: A Literature Review. International journal of molecular sciences 24 (3) (2023)
Tiago Moreira-Gomes, Clevio Nobrega
From the disruption of RNA metabolism to the targeting of RNA-binding proteins: The case of polyglutamine spinocerebellar ataxias. Journal of neurochemistry (2023)
Nádia Silva, Ana Teresa Rajado, Filipa Esteves, David V C Brito, Joana Dias Apolónio, Vânia Palma Roberto, Alexandra Binnie, Inês Maria Araújo, Clevio Nobrega, José Bragança, Pedro Castelo-Branco, null null
Measuring healthy ageing: current and future tools. Biogerontology (2023)
Rodrigo Paulino, Clevio Nobrega
Autophagy in Spinocerebellar Ataxia Type 3: From Pathogenesis to Therapeutics. International journal of molecular sciences 24 (8) (2023)
Elena Grao-Cruces, Carmen M Claro-Cala, Sergio Montserrat-de la Paz, Clevio Nobrega
Lipoprotein Metabolism, Protein Aggregation, and Alzheimer's Disease: A Literature Review. International journal of molecular sciences 24 (3) (2023)
Inês T Afonso, Patrícia Lima, André Conceição, Carlos A Matos, Clevio Nobrega
Mutant Ataxin-2 Expression in Aged Animals Aggravates Neuropathological Features Associated with Spinocerebellar Ataxia Type 2. International journal of molecular sciences 23 (19) (2022)
Adriana Marcelo, Inês T Afonso, Ricardo Afonso-Reis, David V C Brito, Rafael G Costa, Ana Rosa, João Alves-Cruzeiro, Benedita Ferreira, Carina Henriques, Rui J Nobre, Carlos A Matos, Luís Pereira de Almeida, Clevio Nobrega
Autophagy in Spinocerebellar ataxia type 2, a dysregulated pathway, and a target for therapy. Cell death & disease 12 (12) (2021)
Ricardo Afonso-Reis, Inês T Afonso, Clevio Nobrega
Current Status of Gene Therapy Research in Polyglutamine Spinocerebellar Ataxias. International journal of molecular sciences 22 (8) (2021)
Adriana Marcelo, Rebekah Koppenol, Luís Pereira de Almeida, Carlos A Matos, Clevio Nobrega
Stress granules, RNA-binding proteins and polyglutamine diseases: too much aggregation? Cell death & disease 12 (6) (2021)
Ana Vasconcelos-Ferreira, Sara Carmo-Silva, José Miguel Codêsso, Patrick Silva, Alberto Rolim Muro Martinez, Marcondes Cavalcante de França Junior, Clevio Nobrega, Luis Pereira de Almeida
The autophagy-enhancing drug carbamazepine improves neuropathology and motor impairment in mouse models of Machado-Joseph disease. Neuropathology and applied neurobiology (2021)
Carlos A Matos, Luís Pereira de Almeida, Clevio Nobrega
Machado-Joseph disease/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy. Journal of neurochemistry 148 (1) (2018)